2/07/2015 | 10:15 AM The accounting software provider possesses solid growth prospects, as well as sustainable competitive advantages primarily stemming from customer switching costs.
19/06/2015 | 2:15 PM An analysis of global banking systems lends clarity to Morningstar's bank moat methodology.
12/06/2015 | 2:55 PM Morningstar's focus on companies with strong and enduring sustainable competitive advantages generates well above average returns over the long term.
12/06/2015 | 1:54 PM Morningstar's US-based director of content Susan Dziubinski gives investors a breakdown of these index-linked investments that have exploded in popularity.
29/05/2015 | 10:50 AM Morningstar analysts take a look at some of the common holdings among Australian small-cap fund managers.
4/05/2015 | 9:43 AM With South32 driving operations to their potential, the value hidden in global mining giant BHP Billiton can be liberated, Morningstar's Mark Taylor says.
4/05/2015 | 9:40 AM Brambles offers strong growth potential over the next few years linked to its relatively low-risk emerging markets and product growth strategies.
4/05/2015 | 9:39 AM Economic-moat ratings are invaluable in helping build portfolios with attractive risk/return characteristics, as Morningstar analysts explain.
1/05/2015 | 1:59 PM Westpac's cutting of services to the money exchange industry is not enough to cloud OzForex's bright outlook, Morningstar's Nathan Zaia says.
29/04/2015 | 10:10 AM The takeover of Toll Holdings illustrates renewed overseas interest in the Australian industrial sector, Morningstar analysts say.
29/04/2015 | 10:04 AM Share prices in the consumer sector have been driven to lofty heights on strong demand for yield and defensive growth, according to Morningstar analysts.
29/04/2015 | 9:54 AM The resources sector is slightly undervalued with the main pockets of value in the large mining stocks, Morningstar analysts say.
29/04/2015 | 8:25 AM Australian financial services companies are in excellent shape with solid earnings upside likely, Morningstar analysts say.
28/04/2015 | 3:00 PM The chase for yield has pushed share prices of Kiwi companies well above Morningstar's fair value estimates, analysts say.
27/04/2015 | 11:26 AM Yield compression will continue as a meaningful influence on equity markets for the foreseeable future, Morningstar analysts say.
24/04/2015 | 9:11 AM Our most-vetted, highest conviction ideas.
20/04/2015 | 9:56 AM MYOB's indicative price range looks reasonable but the bookbuild process increases risks for retail investors, Morningstar analysts say in their pre-IPO report.
30/03/2015 | 10:30 AM As part of a global review Morningstar has reassessed the moat sources of the four major Australian banks, while still maintaining their wide-moat ratings.
30/03/2015 | 10:06 AM While sentiment towards Crown is fragile and negative news flow shows no signs of easing, the long-term backdrop in Macau is favourable as the region transitions to a more sustainable business model.
30/03/2015 | 9:18 AM Despite a slump in the company's share price, Morningstar doesn't believe disappointing results from a recent clinical trial are disastrous for the Sirtex Medical's prospects.
10/03/2015 | 9:17 AM This well-known Australian law firm ticks all the boxes, having a competitive advantage, a growth strategy and a strong management team.
6/02/2015 | 10:57 AM Following a thorough review of its valuation methodology, Morningstar will be implementing improvements within its global coverage universe of around 1,400 companies in 2015.
4/02/2015 | 8:23 AM Morningstar expects the global plasma market to grow at 5 per cent over the next five years, with higher growth for the top three players including Australia's CSL.
19/12/2014 | 9:15 AM The outlook for the year ahead is still positive but there is no room for complacency, according to Morningstar's Peter Warnes.
23/12/2014 | 9:15 AM
19/12/2014 | 9:15 AM Our most-vetted, highest conviction ideas.
5/12/2014 | 9:15 AM Morningstar's Mark Taylor explores the source of BHP's dividend reliability, its track record of returns to shareholders, while also stress-testing distribution forecasts in an uncertain world.
2/12/2014 | 9:15 AM A clear differentiation strategy has positioned ResMed as one of two globally dominant players in the sleep apnea arena, Morningstar's Chris Kallos says.
21/11/2014 | 9:15 AM Key-person risk often overshadows Platinum's great execution in bolstering the business's strengths and rewarding shareholders.
17/11/2014 | 9:15 AM The demise of small resources is improving diversification in the small-cap index, according to Morningstar analysts.
11/11/2014 | 9:15 AM In this addendum, Morningstar provides guidance as to which moat-rated company suits which strategy or portfolio segment.
3/11/2014 | 9:15 AM A penchant for innovation, strong management and its patent-protected product line grant James Hardie the cost advantage that forms the lynchpin of its narrow economic moat.
3/11/2014 | 9:15 AM Morningstar brings you the full list of companies that have been assigned economic moats in its Australian and New Zealand coverage of some 230 companies.
31/10/2014 | 9:15 AM While cost-out strategies resulted in solid fiscal 2014 earnings, pain in fiscal 2015 is needed to ensure gain in the years that follow.